HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luigi Dogliotti Selected Research

Aromatase Inhibitors

2/2009Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients.
1/2009Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer.
5/2008Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer.
4/2007Changes in bone mineral density after adjuvant aromatase inhibitors and fracture risk in breast cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luigi Dogliotti Research Topics

Disease

25Neoplasms (Cancer)
04/2013 - 06/2002
23Breast Neoplasms (Breast Cancer)
05/2015 - 06/2002
11Prostatic Neoplasms (Prostate Cancer)
04/2013 - 01/2002
7Neoplasm Metastasis (Metastasis)
03/2007 - 01/2002
4Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2014 - 06/2007
4Hypoxia (Hypoxemia)
02/2011 - 08/2006
4Colorectal Neoplasms (Colorectal Cancer)
09/2008 - 01/2004
3Adrenocortical Carcinoma
06/2010 - 09/2005
3Carcinoma (Carcinomatosis)
03/2007 - 09/2002
2Disease Progression
03/2014 - 01/2002
2Restless Legs Syndrome (Restless Legs)
04/2013 - 05/2010
2Transitional Cell Carcinoma
07/2007 - 07/2005
2Osteoporosis
06/2002 - 01/2002
1Hypertension (High Blood Pressure)
03/2014
1Proteinuria
03/2014
1Neutropenia
01/2013
1Residual Neoplasm
10/2010
1Neuroendocrine Carcinoma
11/2009
1Adrenal Cortex Neoplasms (Adrenocortical Cancer)
12/2008
1Hypothyroidism
12/2008
1Rectal Neoplasms (Rectal Cancer)
10/2007
1Hyperplasia
02/2007
1Bone Resorption
01/2007
1Pathologic Complete Response
11/2005

Drug/Important Bio-Agent (IBA)

9Epirubicin (Ellence)FDA LinkGeneric
02/2011 - 10/2002
9Hormones (Hormone)IBA
09/2009 - 02/2003
6Fluorouracil (Carac)FDA LinkGeneric
06/2010 - 01/2005
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2014 - 08/2006
5AndrogensIBA
04/2013 - 01/2002
5TamoxifenFDA LinkGeneric
02/2011 - 08/2006
5AnthracyclinesIBA
02/2011 - 01/2005
5GemcitabineFDA Link
06/2010 - 07/2002
5Letrozole (Femara)FDA LinkGeneric
02/2009 - 09/2002
5Estrogen ReceptorsIBA
01/2009 - 08/2006
5Biomarkers (Surrogate Marker)IBA
11/2008 - 08/2006
5Cisplatin (Platino)FDA LinkGeneric
07/2007 - 07/2002
4Chromogranin AIBA
05/2010 - 02/2007
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2009 - 08/2006
4Aromatase InhibitorsIBA
02/2009 - 04/2007
3Vitamin DFDA LinkGeneric
03/2014 - 01/2002
3Docetaxel (Taxotere)FDA Link
01/2013 - 04/2008
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2011 - 03/2007
3Biological ProductsIBA
02/2011 - 01/2011
3Carbonic Anhydrase IXIBA
02/2011 - 09/2006
3ErbB Receptors (EGF Receptor)IBA
01/2009 - 03/2007
3Mitotane (Lysodren)FDA Link
12/2008 - 09/2005
3Oxaliplatin (Eloxatin)FDA LinkGeneric
09/2008 - 01/2004
3Gonadotropin-Releasing Hormone (GnRH)FDA Link
09/2007 - 01/2002
2Octreotide (Sandostatin)FDA LinkGeneric
03/2014 - 11/2009
2Capecitabine (Xeloda)FDA Link
03/2014 - 06/2010
2Pharmaceutical PreparationsIBA
01/2013 - 01/2011
2Zoledronic Acid (Zometa)FDA Link
05/2009 - 02/2003
2Estrogen Receptor alphaIBA
02/2009 - 01/2009
2Proteins (Proteins, Gene)FDA Link
01/2009 - 01/2007
2AntibodiesIBA
11/2007 - 06/2002
2Doxorubicin (Adriamycin)FDA LinkGeneric
09/2005 - 07/2005
2Etoposide (VP 16)FDA LinkGeneric
09/2005 - 01/2005
2CalciumIBA
09/2002 - 01/2002
1Bevacizumab (Avastin)FDA Link
03/2014
1danusertibIBA
01/2013
1Antineoplastic Agents (Antineoplastics)IBA
06/2011
1Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
02/2011
1EnzymesIBA
02/2011
1Androgen Receptors (Androgen Receptor)IBA
07/2010
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
05/2010
1TOR Serine-Threonine KinasesIBA
01/2009
1Caspase 3 (Caspase-3)IBA
01/2009
1Mitogen-Activated Protein KinasesIBA
01/2009
1Testosterone (Sustanon)FDA Link
12/2008
1human ERBB2 proteinIBA
11/2008
1Irinotecan (Camptosar)FDA LinkGeneric
09/2008
1Sirolimus (Rapamycin)FDA Link
05/2008
1Phosphatidylinositols (Phosphatidylinositol)IBA
05/2008
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
05/2008
1Calcitriol (Calcijex)FDA LinkGeneric
04/2008
1Folic Acid AntagonistsIBA
02/2008
1Thymidylate SynthaseIBA
02/2008
1Somatostatin Receptors (Somatostatin Receptor)IBA
11/2007
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
11/2007
1Leucovorin (Folinic Acid)FDA Link
10/2007
1Prostate-Specific Antigen (Semenogelase)IBA
09/2007
1Carboplatin (JM8)FDA LinkGeneric
07/2007
1Ribosomal Protein S6 Kinases (S6 Kinase)IBA
03/2007
1Transforming Growth Factor alpha (TGF-alpha)IBA
03/2007
1Messenger RNA (mRNA)IBA
01/2007
1HGF activatorIBA
01/2007
1Oxygen (Dioxygen)IBA
08/2006
1Alkaline PhosphataseIBA
07/2005

Therapy/Procedure

21Therapeutics
05/2015 - 01/2002
15Drug Therapy (Chemotherapy)
06/2010 - 06/2002
3Aftercare (After-Treatment)
01/2011 - 08/2006
2Neoadjuvant Therapy
05/2015 - 08/2006
1Radiotherapy
04/2013
1Prostatectomy (Retropubic Prostatectomy)
04/2013
1Castration
01/2013
1Complementary Therapies (Alternative Medicine)
06/2011
1Intravenous Infusions
11/2009
1Immunomodulation
02/2009
1Immunotherapy
02/2009
1Palliative Care (Palliative Therapy)
10/2008